Premium
Vaccine myopia: adult vaccination also needs attention
Author(s) -
Menzies Robert I,
Leask Julie,
Royle Jenny,
MacIntyre C Raina
Publication year - 2017
Publication title -
medical journal of australia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 131
eISSN - 1326-5377
pISSN - 0025-729X
DOI - 10.5694/mja16.00811
Subject(s) - excellence , library science , population , media studies , art , sociology , political science , demography , law , computer science
Summary: In recent years, there has been increasing attention on parents who actively refuse to vaccinate their children. Successive federal governments have increased the amount of family assistance payments at stake for those who do not vaccinate, and removed most incentives for providers to vaccinate. In 2016, the federal government removed vaccine objection as an alternative to vaccination for eligibility to receive family assistance payments. Two states — Victoria and Queensland — introduced legislation to allow the exclusion of unvaccinated children from child care,with no exemption for objectors. The abolition of the conscientious objection process has been championed in sections of the media and by some advocacy groups. Responses to people expressing dissenting views have sometimes been vitriolic. These measures, however, do not address the vast numbers of undervaccinated adults. We estimate that there are about 4.1 million undervaccinated Australians each year; that is, people who are eligible to receive free vaccine(s) under the National Immunisation Program (NIP) but do not receive them. Of these, the children of parents with ideological objections to vaccination are a small subset; the vast majority are adults. Many vaccines are officially recommended for Australians in a range of circumstances, at full cost to the individual, at a subsidised cost or free of charge. The latter category are vaccines that have been added to the NIP Schedule for eligiblegroups,followingexpertadvicethattheyshouldbe provided freeofcharge,based onananalysis ofthe disease burden, vaccine efficacy, safety and cost. In this article, we speci fically discuss NIP vaccines and eligible groups.